Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. - Wikidata - wikimedia - TriplyDB

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program.

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program.

http://www.wikidata.org/entity/Q34140306

about

Structural basis for antagonism and resistance of bicalutamide in prostate cancer Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model Therapeutic androgen receptor ligands.Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models Hepatotoxicity Induced by Antiandrogens: A Review of the Literature Prostate cancer (early).Management of complications of prostate cancer treatment.Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration.Estrogenic side effects of androgen deprivation therapy.Surgical stress delays prostate involution in mice.Prostate cancer management: (1) an update on localised disease Adjuvant goserelin improves clinical disease-free survival and reduces disease-related mortality in patients with locally advanced or localized prostate cancer.Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor Rising prostate-specific antigen after primary prostate cancer therapy.Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer.Improving outcomes in early prostate cancer: Part I--adjuvant treatment.Early and delayed castrations confer a similar survival advantage in TRAMP mice CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism A proposal for the repositioning of prophylactic breast radiotherapy of prostate cancer patients.Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer.Bicalutamide 150 mg: practical prescribing in patients with early prostate cancer.Apples and oranges. Re: 7.4-year update of the ongoing bicalutamide Early Prostate Cancer (EPC) trial programme.What's New in Prostate Cancer, Benign Prostatic Hyperplasia, and Minimally Invasive Surgery?: Highlights from the XIXth Congress of the European Association of Urology, March 23-27, 2004, Vienna, Austria

P2860

Q24523708-90C3E38B-34F1-4267-8CA2-CB30C4A8405A Q24795055-5CB4F0CF-2F07-4844-9183-F636FAEE70BB Q25257846-6121F343-829A-4388-A981-D5234F058814 Q28487784-6A17A315-1F8E-4FB6-85A7-05E318F87B9D Q29543931-213CCBEA-F0C4-4D89-BC38-08A1E5AB54C7 Q33448242-80B6C954-55D5-4E95-8387-046AA999B13A Q33978360-7AB4C245-BCA3-4DBC-9037-904114B02227 Q34487137-D32696B6-A9E1-44BC-A5F7-CDD88ED4EBC7 Q34537714-4DDCF83E-2CAF-4C73-8031-036DF7CEE1C0 Q34743239-9AC2CC9B-C9E5-4783-A5D5-564C7D329993 Q35040157-28F70FEA-5FE5-46B0-AF62-7CC4ADB43DED Q35517935-5D108262-6BCD-43D6-926D-22F52B2DEC6C Q35608929-DAC9C528-8D0C-4EC3-9118-CF70B7FEBA40 Q35691973-AC1207E1-FF16-4E0A-B0F0-D76921A678A3 Q36395149-DB7C7936-CC9C-4503-B4FA-1D24F3EB1047 Q36432836-864297AE-F931-46E5-86A7-32E4D41FAF48 Q36595214-56FFCF8E-E26E-4BBC-81C2-04A575CEE297 Q37074958-88064466-99EB-49BA-8787-EAFC89E759F2 Q40002581-219377CD-9F2B-4E2B-B385-F0E5718B527F Q40340176-D7AA6AF8-EB90-4260-9E5F-5B6DE7FDA792 Q44803546-3DB243D8-F6D4-4EE2-A5A4-CD5E1E9DBEC2 Q45100344-E738CFE4-AF78-4230-AECD-39020CA5CDB2 Q46936634-7A7A1147-D936-47DE-92D5-C3D99E9956D5 Q57657325-FD3A7F8E-BB2E-4AF9-94C1-86AE5DC7560F

P2860

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program.

http://www.wikidata.org/entity/Q34140306

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Bicalutamide as immediate ther ...... early prostate cancer program.

@ast

Bicalutamide as immediate ther ...... early prostate cancer program.

@en

Bicalutamide as immediate ther ...... early prostate cancer program.

@nl

type

label

Bicalutamide as immediate ther ...... early prostate cancer program.

@ast

Bicalutamide as immediate ther ...... early prostate cancer program.

@en

Bicalutamide as immediate ther ...... early prostate cancer program.

@nl

prefLabel

Bicalutamide as immediate ther ...... early prostate cancer program.

@ast

Bicalutamide as immediate ther ...... early prostate cancer program.

@en

Bicalutamide as immediate ther ...... early prostate cancer program.

@nl

P1433

Q34140306-DB2191C7-62CE-4EC0-87A4-405D2AB8FC1E

P1476

Q34140306-0023E4AB-F203-40A1-A7CE-03622FD62A8A

P2093

Q34140306-04C85D9C-8D5B-435C-8AAB-C20F3BC81D3D

Q34140306-05C21AC5-8C19-4BE7-B1EE-7FB58BEF22FF

Q34140306-13807A11-88AF-4040-A57E-C15A0B72E595

Q34140306-250EF983-4ED1-4E0C-A54F-D9B6E1B348B0

Q34140306-42601E7C-229F-45B4-977F-CE28DC5F5954

Q34140306-82578757-91EA-4133-945F-C59F7E19995C

Q34140306-82E3A8CA-DB05-4B1E-A8B6-0DA1A34E4D37

Q34140306-87D26A0C-6ADF-4E43-B696-96B8F4519ABB

Q34140306-9C186590-2EF1-46A1-9C59-20D14B82B772

Q34140306-AF3EA4E9-397A-4923-977D-8A5630662D5B

P304

Q34140306-A18A9493-E6DA-40A9-BE68-3AF5A37BACFE

P31

Q34140306-B1A71418-F09E-4E55-AD8A-C002585CC307

P356

Q34140306-41C60641-B861-4C66-AF6A-1E567767B8A9

P407

Q34140306-47BFD571-E5C9-4CD2-AFC3-3B41A63B9322

P433

Q34140306-630B129B-E9C7-4B86-804B-E4998C3B6A2E

P478

Q34140306-6C3685DB-4B83-4A02-8B0B-298BB19DA0D6

P577

Q34140306-0FD2BD46-DFD3-4F61-B22E-E88AE5F7852B

P698

Q34140306-0FF21E4A-9730-44F4-8BE5-B1F02A66CA60

P356

00005392-200208000-00006

P1433

The Journal of Urology

P1476

Bicalutamide as immediate ther ...... early prostate cancer program.

@en

P2093

Bo-Eric Persson

http://www.w3.org/2001/XMLSchema#string

Casodex Early Prostate Cancer Trialist Group

http://www.w3.org/2001/XMLSchema#string

Chris Tyrrell

http://www.w3.org/2001/XMLSchema#string

D M A Wallace

http://www.w3.org/2001/XMLSchema#string

David G McLeod

http://www.w3.org/2001/XMLSchema#string

Donald Gleason

http://www.w3.org/2001/XMLSchema#string

Geert J C M Kolvenbag

http://www.w3.org/2001/XMLSchema#string

Gerald Chodak

http://www.w3.org/2001/XMLSchema#string

Ira Klimberg

http://www.w3.org/2001/XMLSchema#string

James Montie

http://www.w3.org/2001/XMLSchema#string

P304

429-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00005392-200208000-00006

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12131282

http://www.w3.org/2001/XMLSchema#string